A target for antiangiogenic therapy: Vascular endothelium derived from glioblastoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 11, 2011, Pages 4271-4272

  Hormigo, Adília ^a,b,c   Ding, Bi Sen ^a   Rafii, Shahin ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; BEVACIZUMAB; KALININ; LAMININ 5 GAMMA 2; NEUROPILIN 2; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANTIANGIOGENIC THERAPY; APOPTOSIS; AUTOPHOSPHORYLATION; CANCER RESISTANCE; CANCER SURVIVAL; CELL PROLIFERATION; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GLIOBLASTOMA; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR NECROSIS; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL TRANSDIFFERENTIATION; ENDOTHELIAL CELLS; GLIOBLASTOMA; HUMANS; MICE; TUMOR MARKERS, BIOLOGICAL;

EID: 79952728557     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1019656108     Document Type: Note

References (20)

1. Stupp R, et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996.
2. Kreisl TN, et al. (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27:740-745.
3. Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14:53-65. (Pubitemid 8153798)
4. Holash J, et al. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998. (Pubitemid 29309448)
5. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: Biology and molecular pathophysiology. Brain Pathol 15:297-310.
6. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
7. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
8. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B (2002) Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826-835.
9. De Palma M, et al. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211-226. (Pubitemid 41317592)
10. Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA (2006) Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 66:9054-9064. (Pubitemid 44521124)
11. Soda Y, et al. (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 108:4274-4280.
12. Marumoto T, et al. (2009) Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15:110-116.
13. Shojaei F, Ferrara N (2008) Refractoriness to antivascular endothelial growth factor treatment: Role of myeloid cells. Cancer Res 68:5501-5504.
14. Butler JM, Kobayashi H, Rafii S (2010) Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 10:138-146.
15. Maniotis AJ, et al. (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol 155:739-752. (Pubitemid 29426820)
16. El Hallani S, et al. (2010) A new alternative mechanism in glioblastoma vascularization: Tubular vasculogenic mimicry. Brain 133:973-982.
17. Hooper AT, et al. (2009) Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4:263-274.
18. Ricci-Vitiani L, et al. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824-828.
19. Wang R, et al. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829-833.
20. Rafii S, Lyden D (2008) Cancer. A few to flip the angiogenic switch. Science 319:163-164.